Acknowledgement to Reviewers

The thematic issue, "Advances in Nanocarrier-Based Strategies for Gastrointestinal and Hepatic Cancer Therapy," will serve as a comprehensive platform to highlight the latest innovations and breakthroughs in nanocarrier-mediated drug delivery systems targeting gastrointestinal (GI) and hepatic cancer. This issue aims to bring together original research and critical reviews on the ...read more

Oral drug delivery remains the most preferred route for pharmaceutical administration due to its convenience, patient compliance, and cost-effectiveness. However, challenges such as poor bioavailability, instability, and lack of targeted delivery necessitate continuous innovation in formulation and drug delivery technologies. This special issue explores cutting-edge advancements in oral dosage forms, ...read more

Glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have revolutionized the management of type 2 diabetes and obesity, with emerging benefits across cardiovascular, renal, and metabolic diseases. However, their peptide nature poses significant challenges for formulation and delivery. Recent advances (2022–2025) have focused on innovative delivery modalities, including long‑acting injectables, depot systems, ...read more

The development of smart nanocarriers has revolutionized the field of targeted drug delivery by enhancing therapeutic efficacy, minimizing systemic toxicity, and improving patient compliance. This thematic issue will explore state-of-the-art advancements in nanocarrier-based drug delivery systems, including lipid-based, polymeric, and hybrid nanocarriers, as well as novel approaches such as microneedles, ...read more